FDA Identifies Issues at Neuralink's Animal Lab

Neuralink cleared for human trials despite identified lab issues, raising concerns.

FDA inspectors found issues with record keeping and quality controls for animal experiments at Neuralink's California facility.
Neuralink was cleared for human trials of its brain implant technology despite these issues.
The brain implant aims to help patients with paralysis communicate using thoughts to move a computer device.
Concerns were raised about potential animal-welfare violations at Neuralink, but the FDA has not designated the issues as significant enough to prompt action.
Neuralink's first human trial participant has reportedly made a full recovery, with the company continuing to monitor safety.